Omkar Pharmachem Ltd
Incorporated in 1995, Omkar Pharmachem Ltd manufactures chemicals used in pharmaceuticals.
- Market Cap ₹ 28.1 Cr.
- Current Price ₹ 27.9
- High / Low ₹ 30.1 / 22.0
- Stock P/E 140
- Book Value ₹ 9.35
- Dividend Yield 0.00 %
- ROCE 3.04 %
- ROE 2.14 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Stock is trading at 2.98 times its book value
- Promoter holding is low: 0.03%
- Company has a low return on equity of 2.15% over last 3 years.
- Working capital days have increased from 51.8 days to 74.4 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.27 | 0.54 | 0.54 | 0.54 | 0.54 | |
0.07 | 0.06 | 0.12 | 0.22 | 0.24 | 0.38 | 0.26 | 0.24 | 0.27 | 0.22 | 0.25 | 0.24 | |
Operating Profit | 0.00 | -0.06 | -0.12 | -0.22 | -0.24 | -0.38 | -0.21 | 0.03 | 0.27 | 0.32 | 0.29 | 0.30 |
OPM % | 0.00% | -420.00% | 11.11% | 50.00% | 59.26% | 53.70% | 55.56% | |||||
0.00 | 0.00 | 0.00 | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 | 0.05 | 0.06 | 0.06 | 0.05 | 0.03 | 0.02 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Profit before tax | 0.00 | -0.06 | -0.12 | 0.27 | -0.25 | -0.42 | -0.26 | -0.03 | 0.21 | 0.27 | 0.26 | 0.27 |
Tax % | 0.00% | 0.00% | 18.52% | 0.00% | 0.00% | 0.00% | -866.67% | 14.29% | 25.93% | 23.08% | 25.93% | |
0.00 | -0.06 | -0.12 | 0.22 | -0.26 | -0.42 | -0.26 | 0.22 | 0.18 | 0.20 | 0.19 | 0.20 | |
EPS in Rs | 0.00 | -0.06 | -0.12 | 0.22 | -0.26 | -0.42 | -0.26 | 0.22 | 0.18 | 0.20 | 0.19 | 0.20 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 61% |
3 Years: | 0% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 18% |
5 Years: | 23% |
3 Years: | 4% |
TTM: | 5% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | 9% |
1 Year: | 27% |
Return on Equity | |
---|---|
10 Years: | 0% |
5 Years: | 2% |
3 Years: | 2% |
Last Year: | 2% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 |
Reserves | -0.75 | -0.81 | -0.93 | -0.71 | -0.96 | -1.38 | -1.64 | -1.42 | -1.24 | -1.04 | -0.85 | -0.65 |
0.01 | 0.01 | 0.00 | 0.00 | 0.24 | 0.58 | 0.87 | 0.90 | 0.93 | 0.62 | 0.30 | 0.12 | |
0.11 | 0.13 | 0.57 | 0.06 | 0.04 | 0.05 | 0.06 | 0.08 | 0.06 | 0.07 | 0.07 | 0.05 | |
Total Liabilities | 9.45 | 9.41 | 9.72 | 9.43 | 9.40 | 9.33 | 9.37 | 9.64 | 9.83 | 9.73 | 9.60 | 9.60 |
0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 |
0.14 | 0.10 | 0.41 | 0.13 | 0.09 | 0.03 | 0.07 | 0.34 | 0.52 | 0.43 | 0.29 | 0.29 | |
Total Assets | 9.45 | 9.41 | 9.72 | 9.43 | 9.40 | 9.33 | 9.37 | 9.64 | 9.83 | 9.73 | 9.60 | 9.60 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.01 | -0.05 | 0.34 | -0.77 | -0.25 | -0.30 | -0.21 | 0.02 | 0.20 | 0.28 | 0.30 | ||
0.00 | 0.00 | 0.00 | 0.49 | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | ||
0.00 | 0.00 | -0.01 | 0.01 | 0.23 | 0.30 | 0.24 | -0.02 | -0.03 | -0.35 | -0.35 | ||
Net Cash Flow | 0.01 | -0.05 | 0.33 | -0.28 | -0.03 | 0.00 | 0.02 | 0.00 | 0.17 | -0.08 | -0.06 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 365.00 | 146.00 | 40.56 | 54.07 | 87.87 | 33.80 | 67.59 | |||||
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 365.00 | 146.00 | 40.56 | 54.07 | 87.87 | 33.80 | 67.59 | |||||
Working Capital Days | -52.14 | -219.00 | -54.07 | 20.28 | 40.56 | 40.56 | 74.35 | |||||
ROCE % | 0.00% | -0.64% | -1.30% | -2.27% | -2.56% | -4.08% | -2.26% | 0.32% | 2.79% | 3.29% | 3.02% | 3.04% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2d - Dear Sir, Please find attached News paper publication of Audited results of Quarter and year ended on 31st March 2025
-
Announcement under Regulation 30 (LODR)-Change in Management
2d - Audited FY25 results approved; new secretarial auditor appointed for five years starting FY26.
- Results- Financial Results For March 31, 2025 2d
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 29Th May 2025 For Approval Of Audited Financial Statements For Quarter And Year Ended On March 2025
2d - Auditor's report confirms true and fair standalone financial results for FY ended March 31, 2025.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
27 May - Annual Secretarial Compliance Report for FY 2024-25 confirming regulatory compliance.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:[1][2]
a) Sodium bi-sulphite
b) Sodium meta bi-sulphite
c) Sodium sulphite
d) Sulphur
e) Specialty chemicals
f) Ciba specialty chemicals
g) Organic chemicals